| Literature DB >> 31477037 |
Honglan Wei1, Yaqiong Yan2, Jie Gong3, Junwu Dong4.
Abstract
BACKGROUND: In China, both population aging and kidney damage has become emerging public health challenges. Despite the number of elders is huge, data on kidney damage in this population are scarce. The present study aimed to describe the prevalence of kidney damage among older adults in Wuhan, China.Entities:
Keywords: Chinese elderly; Epidemiology; Kidney damage
Year: 2019 PMID: 31477037 PMCID: PMC6719360 DOI: 10.1186/s12882-019-1525-5
Source DB: PubMed Journal: BMC Nephrol ISSN: 1471-2369 Impact factor: 2.388
Age and sex distribution of study population
| Sex | Age, n (%) | Total | ||||
|---|---|---|---|---|---|---|
| 65~ | 70~ | 75~ | 80~ | |||
| Urban | Male | 29,454 (37.7) | 22,499 (28.8) | 17,276 (22.1) | 8871 (11.4) | 78,100 (45.4) |
| Female | 36,417 (38.8) | 27,798 (29.6) | 20,170 (21.5) | 9543 (10.1) | 93,928 (54.6) | |
| Total | 65,871 (38.3) | 50,297 (29.2) | 37,446 (21.8) | 18,414 (10.7) | 172,028 (49.0) | |
| Suburbs | Male | 37,399 (43.8) | 25,645 (30.0) | 15,001 (17.6) | 7309 (8.6) | 85,354 (47.7) |
| Female | 41,107 (44.0) | 26,168 (28.0) | 15,845 (16.9) | 10,379 (11.1) | 93,499 (52.3) | |
| Total | 78,506 (43.9) | 51,813 (29.0) | 30,846 (17.2) | 17,688 (9.9) | 178,853 (51.0) | |
| Total | Male | 66,853 (40.9) | 48,144 (29.5) | 32,277 (19.7) | 16,180 (9.9) | 163,454 (46.6) |
| Female | 77,524 (41.4) | 53,966 (28.8) | 36,015 (19.2) | 19,922 (10.6) | 187,427 (53.4) | |
| Total | 144,377 (41.1) | 102,110 (29.1) | 68,292 (19.5) | 36,102 (10.3) | 350,881 (100.0) | |
Clinical characteristics of study population
| Male | Female | Total | |
|---|---|---|---|
| Systolic blood pressure (mmHg) | 134.5 ± 20.4* | 135.7 ± 21.0 | 135.1 ± 20.7 |
| Diastolic blood pressure (mmHg) | 80.9 ± 11.3* | 79.9 ± 11.1 | 80.4 ± 11.2 |
| Blood urea nitrogen (mmol/L) | 6.1 ± 2.3* | 5.7 ± 2.3 | 5.9 ± 2.3 |
| Serum creatinine (μmol/L) | 90.4 ± 26.9* | 74.7 ± 23.2 | 82.0 ± 26.2 |
| Blood cholesterol (mmol/L) | 4.7 ± 1.1* | 5.1 ± 1.1 | 4.9 ± 1.1 |
| Serum triglyceride (mmol/L) | 1.0 (0.7–1.5) | 1.3 (0.9–1.8) | 1.2 (0.8–1.7) |
| Fast blood glucose (mmol/L) | 5.5 ± 1.4* | 5.5 ± 1.5 | 5.5 ± 1.5 |
| BMI | 23.0 ± 3.3* | 23.4 ± 3.6 | 23.2 ± 3.5 |
| Abdominal circumference (cm) | 83.5 ± 8.9* | 81.7 ± 9.0 | 82.5 ± 9.0 |
| Diabetes(n, %) | 18,623 (11.5)* | 24,923 (13.4) | 43,546 (12.5) |
| Hypertension(n, %) | 95,560 (58.9)* | 114,831 (61.8) | 210,391 (60.5) |
| Hyperlipidaemia(n, %) | 27,361 (16.8)* | 51,573 (27.6) | 78,934 (22.6) |
| Obesity(n, %) | 11,011 (6.7)* | 18,734 (10.0) | 29,745 (8.5) |
| Coronary heart disease(n, %) | 11,154 (6.9)* | 15,086 (8.1) | 26,240 (7.5) |
| Stroke(n, %) | 6377 (3.9)* | 6135 (3.3) | 12,512 (3.6) |
*P < 0.05
The percentages of decreased renal function in urban and suburbs
| Sex | Grades, n (%) | Total | |||
|---|---|---|---|---|---|
| G3 | G4 | G5 | |||
| Urban | Male | 8698 (11.2) | 382 (0.5) | 77 (0.1) | 9157 (11.7) |
| Female | 10,217 (10.9) | 419 (0.5) | 102 (0.1) | 10,738 (11.5) | |
| Total | 18,915 (11.0) | 801 (0.5) | 179 (0.1) | 19,895 (11.6) | |
| Suburbs | Male | 8939 (10.5) | 369 (0.4) | 63 (0.1) | 9371 (11.0) |
| Female | 14,227 (15.2) | 375 (0.4) | 81 (0.1) | 14,683 (15.7) * | |
| Total | 23,166 (12.9) | 744 (0.4) | 144 (0.1) | 24,054 (13.4) * | |
| Total | Male | 17,637 (10.8) | 751 (0.5) | 140 (0.1) | 18,528 (11.4) |
| Female | 24,444 (13.0) | 794 (0.4) | 183 (0.1) | 25,421 (13.5) * | |
| Total | 42,081 (12.0) | 1545 (0.4) | 323 (0.1) | 43,949 (12.5) | |
*P < 0.05
The percentages of renal function decline in different age groups
| Crude, n (%) | Adjusted(95%CI) | ||||
|---|---|---|---|---|---|
| 65~ | 70~ | 75~ | 80~ | ||
| Urban | |||||
| G3 | 4247 (6.5) | 5266 (10.5) | 5508 (14.7) | 3894 (21.2) | 11.8 (11.7–11.9) |
| G4 | 154 (0.2) | 203 (0.4) | 213 (0.6) | 231 (1.3) | 0.5 (0.48–0.52) |
| G5 | 52 (0.1) | 54 (0.1) | 42 (0.1) | 31 (0.2) | 0.1 (0.09–0.11) |
| Suburbs | |||||
| G3 | 7631 (9.7) | 6564 (12.7) | 5294 (17.2) | 3677 (20.8) | 14.0 (13.9–14.1) * |
| G4 | 196 (0.3) | 211 (0.4) | 182 (0.6) | 155 (0.9) | 0.5 (0.48–0.52) |
| G5 | 50 (0.1) | 44 (0.1) | 30 (0.1) | 20 (0.1) | 0.1 (0.09–0.11) |
| Total | |||||
| G3 | 11,878 (8.2) | 11,830 (11.6) | 10,802 (15.8) | 7571 (21.0) | 12.9 (12.8–13.0) * |
| G4 | 350 (0.2) | 414 (0.4) | 395 (0.6) | 386 (1.1) | 0.5 (0.48–0.52) |
| G5 | 102 (0.1) | 98 (0.1) | 72 (0.1) | 51 (0.1) | 0.1 (0.09–0.11) |
*P < 0.05
Prevalence of decreased renal function, proteinuria and kidney damage
| eGFR< 60 mL/min/1.73 m2 | Proteinuria | Kidney damage | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Total | Positive | Prevalence | Total | Positive | Prevalence | Total | Positive | Prevalence | |
| Urban | 172,088 | 19,895 | 11.6 | 172,088 | 8690 | 5.1 | 172,088 | 25,933 | 15.1 |
| Suburbs | 178,853 | 24,054 | 13.4* | 178,853 | 9168 | 5.1 | 178,853 | 30,610 | 17.1* |
| Total | 350,881 | 43,949 | 12.5 | 350,881 | 17,858 | 5.1 | 350,881 | 56,543 | 16.1 |
*P < 0.05
Fig. 1Prevalence of proteinuria by sex in different districts
Fig. 2Prevalence of proteinuria by 5-year age groups in different districts
Prevalence of kidney damage by sex in different districts
| Crude, n (%) | Adjusted for age (%)(95%CI) | |||
|---|---|---|---|---|
| Male | Female | Total | ||
| Urban | 12,057 (15.4) * | 13,876 (14.8) | 25,933 (15.1) | 16.0 (15.9–16.1) |
| Suburbs | 12,708 (14.9) | 17,902 (19.2) * | 30,610 (17.1) * | 18.3 (18.2–18.4) * |
| Total | 24,765 (15.2) | 31,778 (17.0) * | 56,543 (16.1) | 17.2 (17.1–17.3) |
*P < 0.05
Fig. 3Prevalence of kidney damage by 5-year age groups in elders
Factors associated with kidney damage
| eGFR< 60 ml/min/1.73m2 | Kidney damage | |||
|---|---|---|---|---|
| OR | 95%CI | OR | 95%CI | |
| Age | 1.422 | 1.374–1.473 | 1.069 | 1.044–1.095 |
| Female | 1.092 | 1.071–1.12 | 1.099 | 1.079–1.120 |
| BMI | 1.082 | 1.068–1.096 | 1.080 | 1.067–1.094 |
| Abdominal circumference | 1.112 | 1.090–1.134 | 1.108 | 1.086–1.130 |
| Hypertension | 1.575 | 1.543–1.607 | 1.577 | 1.546–1.609 |
| Diabetes | 1.614 | 1.575–1.654 | 1.626 | 1.587–1.667 |
| Stroke | 1.276 | 1.221–1.334 | 1.275 | 1.220–1.332 |
| Coronary heart disease | 1.243 | 1.204–1.283 | 1.239 | 1.201–1.279 |